Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medicines for children--the last century and the next.

Authors: B Djulbegovic; M Lacevic; A Cantor; K K Fields; C L Bennett; J R Adams; N M Kuderer; G H Lyman
Journal: Lancet Date: 2000-08-19 Impact factor: 79.321

6. Unlicensed and off label drug use in paediatric wards: prospective study.

Authors: S Turner; A Longworth; A J Nunn; I Choonara
Journal: BMJ Date: 1998-01-31

7. Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

Authors: S Turner; A Gill; T Nunn; B Hewitt; I Choonara
Journal: Lancet Date: 1996-02-24 Impact factor: 79.321

8. Gaining patients' consent. Telling parents all relevant details might reduce recruitment of children to trials.

Authors: T Stephenson; D A Walker
Journal: BMJ Date: 1996-08-10

9. Off label and unlicensed drug use among French office based paediatricians.

Authors: M Chalumeau; J M Tréluyer; B Salanave; R Assathiany; G Chéron; N Crocheton; C Rougeron; M Mares; G Bréart; G Pons
Journal: Arch Dis Child Date: 2000-12 Impact factor: 3.791

10. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors: S Turner; A J Nunn; K Fielding; I Choonara
Journal: Acta Paediatr Date: 1999-09 Impact factor: 2.299

8 in total

Review 1. Dose estimation for children.

Authors: Nigel Baber; Deborah Pritchard
Journal: Br J Clin Pharmacol Date: 2003-11 Impact factor: 4.335

Medicines for children--the last century and the next.

1. Support for studies in paediatric medicine is needed.

2. Investigating allegations of research misconduct. Worst outcome of Griffiths report would be that research becomes increasingly difficult.

3. Unlicensed and off label prescribing of drugs in general practice.

4. Who is speaking for children and adolescents and for their health at the policy level?

5. The uncertainty principle and industry-sponsored research.

6. Unlicensed and off label drug use in paediatric wards: prospective study.

7. Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

8. Gaining patients' consent. Telling parents all relevant details might reduce recruitment of children to trials.

9. Off label and unlicensed drug use among French office based paediatricians.

10. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Review 1. Dose estimation for children.

Review 2. Emergency management of meningococcal disease: eight years on.

Review 3. The future of neonatal therapeutic trials.

Review 4. The EU's new paediatric medicines legislation: serving children's needs?

5. Unlicensed and off-label drug use: issues and recommendations.

6. Off-label drug use in a Pediatric Intensive Care Unit.

7. Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?

8. Insufficient access to oral paediatric medicines in Ghana: A descriptive study.